20 Hrs
Source:
بوابة الشروق
Drug Division introduces flexible pricing for new products with a 10% dollar rate shift
The article discusses Egypt's Drug Authority decision to implement a new drug pricing system based on economic indicators such as exchange rates, inflation, and interest rates, with the aim of organizing the market, ensuring transparency, and attracting foreign investment. It confirms that this system—which applies only to new products—monitors dollar price movements, requiring a 10% increase and a stability period of 45 days before prices are adjusted using a formula that allocates weights as follows: 60% to exchange rate changes, 30% to inflation, and 10% to bank interest rates. It also notes that the last drug pricing decision was made about 14 years ago, and the new system comes after procedural complexities, with expectations that the first modified products will appear in the market within one to two years.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)